Epiontis ID: Use Cases Across Diverse Therapeutic Areas Reza Sedaghat2023-08-28T11:24:59-04:00Resources| Read More
Using Epigenetic Immune Cell Profiling to Provide Insight into the Tumor Microenvironment in B-Cell Non-Hodgkin Lymphoma Reza Sedaghat2023-08-28T10:35:02-04:00Resources| Read More
FOXP3 TSDR Measurement Could Assist Variant Classification and Diagnosis of IPEX Syndrome Reza Sedaghat2023-01-09T05:58:55-05:00Resources| Read More
Using Epiontis ID for Evaluating COVID-19 Disease Course and Measuring SARS-CoV-2 Vaccine Response Reza Sedaghat2022-10-06T10:48:50-04:00Resources| Read More
Exploring Biomarkers to Predict the Response to Immunotherapy-Based Combination Treatment in Hepatocellular Carcinoma Using Epiontis ID™ Reza Sedaghat2022-10-06T10:33:50-04:00Resources| Read More
Epigenetic Immune Cell Counting in Human Blood Samples for Immunodiagnostics Carlos Bonilla2022-08-08T17:02:06-04:00Resources| Read More
Effect of Ozanimod on Circulating Leukocyte Subtypes in Patients With Relapsing Multiple Sclerosis and Comparison With Healthy Volunteers Carlos Bonilla2022-08-08T17:00:58-04:00Resources| Read More
Effects on CD3, Treg, and TH17 Cell Numbers in Skin Biopsies After 16-Week Mirikizumab Treatment, Evaluated by an Epigenetic Assay Carlos Bonilla2022-08-08T17:01:14-04:00Resources| Read More
Interim Biomarker Analysis of Etigilimab (OMP-313M32), an Anti-TIGIT Antibody, in Advanced Solid Tumors Supports TIGIT-Associated Mechanisms of Action Carlos Bonilla2022-08-08T17:01:39-04:00Resources| Read More
Quantifying Circulating Th17 Cells by qPCR: Potential as Diagnostic Biomarker for Rheumatoid Arthritis Carlos Bonilla2022-08-08T17:03:05-04:00Resources| Read More
